Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to AU$18.02, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Construction industry in Australia. Total returns to shareholders of 102% over the past three years. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to AU$14.77, the stock trades at a trailing P/E ratio of 16.5x. Average forward P/E is 19x in the Construction industry in Australia. Total returns to shareholders of 73% over the past three years. Board Change • May 20
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Robert Radici was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • May 01
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Robert Radici was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Feb 04
Lycopodium Limited to Report First Half, 2026 Results on Feb 18, 2026 Lycopodium Limited announced that they will report first half, 2026 results on Feb 18, 2026 Board Change • Dec 24
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Robert Radici was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Oct 03
Lycopodium Limited, Annual General Meeting, Nov 13, 2025 Lycopodium Limited, Annual General Meeting, Nov 13, 2025. Declared Dividend • Aug 22
Final dividend of AU$0.25 announced Shareholders will receive a dividend of AU$0.25. Ex-date: 18th September 2025 Payment date: 3rd October 2025 Dividend yield will be 2.9%, which is lower than the industry average of 3.6%. Sustainability & Growth Dividend is well covered by both earnings (33% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has increased by an average of 18% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 30% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Announcement • Aug 22
Lycopodium Limited Approves Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2025, Payable on 3 October 2025 Lycopodium Limited have approved a fully franked ordinary dividend of AUD 0.25000000 per share for the six months ended June 30, 2025, payable on 3 October 2025. Ex Date is September 18, 2025. Record Date is September 19, 2025. Reported Earnings • Aug 21
Full year 2025 earnings released: EPS: AU$1.06 (vs AU$1.28 in FY 2024) Full year 2025 results: EPS: AU$1.06 (down from AU$1.28 in FY 2024). Revenue: AU$333.9m (down 3.1% from FY 2024). Net income: AU$42.2m (down 17% from FY 2024). Profit margin: 13% (down from 15% in FY 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Aug 18
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Non-Executive & Independent Director Robert Radici was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Jul 28
Lycopodium Limited to Report Fiscal Year 2025 Results on Aug 20, 2025 Lycopodium Limited announced that they will report fiscal year 2025 results on Aug 20, 2025 Announcement • Feb 18
Lycopodium Limited (ASX:LYL) acquired 60% stake in Saxum Ingenieria S.a Lycopodium Limited (ASX:LYL) entered into a Heads of Agreement to acquire 60% stake in Saxum Ingenieria S.a on October 18, 2024. Under the terms of the agreement, Lycopodium will acquire a 60% shareholding in SAXUM with options over the remaining share capital in subsequent years, being 25% on the fifth anniversary of the completion date and 15% on the seventh anniversary of the completion date. Post-acquisition, the SAXUM brand will be retained and the company will continue to be managed by the incumbent leadership team. The acquisition will be funded from cash reserves, and it is anticipated the purchase will be finalised in Q1 2025.
Lycopodium Limited (ASX:LYL) completed the acquisition of 60% stake in Saxum Ingenieria S.a on February 18, 2025. The purchase price of $7.1 million is fully funded from cash reserves. Announcement • Feb 12
Lycopodium Limited to Report First Half, 2025 Results on Feb 19, 2025 Lycopodium Limited announced that they will report first half, 2025 results on Feb 19, 2025 Board Change • Feb 04
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Louise Bower was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Dec 24
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Louise Bower was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Oct 18
Lycopodium Limited (ASX:LYL) entered into a Heads of Agreement to acquire 60% stake in Saxum Ingenieria S.a. Lycopodium Limited (ASX:LYL) entered into a Heads of Agreement to acquire 60% stake in Saxum Ingenieria S.a on October 18, 2024. Under the terms of the agreement, Lycopodium will acquire a 60% shareholding in SAXUM with options over the remaining share capital in subsequent years. Post-acquisition, the SAXUM brand will be retained and the company will continue to be managed by the incumbent leadership team. The acquisition will be funded from cash reserves, and it is anticipated the purchase will be finalised in Q1 2025. Announcement • Oct 04
Lycopodium Limited, Annual General Meeting, Nov 12, 2024 Lycopodium Limited, Annual General Meeting, Nov 12, 2024. Upcoming Dividend • Sep 12
Upcoming dividend of AU$0.40 per share Eligible shareholders must have bought the stock before 19 September 2024. Payment date: 04 October 2024. Payout ratio is a comfortable 60% but the company is paying out more than the cash it is generating. Trailing yield: 6.2%. Within top quartile of Australian dividend payers (6.2%). Higher than average of industry peers (3.8%). Recent Insider Transactions • Aug 25
Independent Non-Executive Director recently bought AU$98k worth of stock On the 23rd of August, Steven Chadwick bought around 8k shares on-market at roughly AU$12.20 per share. This transaction amounted to 41% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$707k more in shares than they bought in the last 12 months. Announcement • Aug 23
Lycopodium Limited Approves A Fully Franked Final Dividend for the Six Months Ended June 30, 2024, Payable on 4 October 2024 Lycopodium Limited have approved a fully franked final dividend of 40 cents per share for the six months ended June 30, 2024, payable on 4 October 2024, bringing the full-year dividend to 77 cents per share. Ex Date is September 19, 2024. Record Date is September 20, 2024. Declared Dividend • Aug 23
Final dividend of AU$0.40 announced Shareholders will receive a dividend of AU$0.40. Ex-date: 19th September 2024 Payment date: 4th October 2024 Dividend yield will be 6.3%, which is higher than the industry average of 3.6%. Sustainability & Growth Dividend is covered by earnings (0.7379% earnings payout ratio) but not covered by cash flows (133% cash payout ratio). The dividend has increased by an average of 8.6% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 25% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Buy Or Sell Opportunity • Aug 21
Now 28% undervalued The stock has been flat over the last 90 days, currently trading at AU$12.36. The fair value is estimated to be AU$17.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 26% over the last 3 years. Earnings per share has grown by 40%. Announcement • Aug 14
Lycopodium Limited to Report Fiscal Year 2024 Results on Aug 21, 2024 Lycopodium Limited announced that they will report fiscal year 2024 results on Aug 21, 2024 Buy Or Sell Opportunity • Aug 05
Now 25% undervalued The stock has been flat over the last 90 days, currently trading at AU$12.95. The fair value is estimated to be AU$17.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 52%. Buy Or Sell Opportunity • Jun 04
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.9% to AU$11.86. The fair value is estimated to be AU$14.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 52%. Buy Or Sell Opportunity • May 17
Now 20% undervalued The stock has been flat over the last 90 days, currently trading at AU$12.00. The fair value is estimated to be AU$15.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 52%. Recent Insider Transactions • Mar 30
Executive Director recently sold AU$17m worth of stock On the 25th of March, Bruno Ruggiero sold around 2m shares on-market at roughly AU$11.21 per share. This transaction amounted to 51% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$19m more than they bought in the last 12 months. Upcoming Dividend • Mar 18
Upcoming dividend of AU$0.37 per share Eligible shareholders must have bought the stock before 25 March 2024. Payment date: 04 April 2024. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 6.8%. Within top quartile of Australian dividend payers (6.3%). Higher than average of industry peers (3.4%). Buy Or Sell Opportunity • Mar 15
Now 20% undervalued Over the last 90 days, the stock has risen 14% to AU$12.12. The fair value is estimated to be AU$15.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 52%. Recent Insider Transactions • Mar 12
MD & Executive Director recently sold AU$643k worth of stock On the 8th of March, Peter De Leo sold around 50k shares on-market at roughly AU$12.85 per share. This transaction amounted to 5.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Peter's only on-market trade for the last 12 months. Declared Dividend • Feb 23
First half dividend of AU$0.37 announced Shareholders will receive a dividend of AU$0.37. Ex-date: 25th March 2024 Payment date: 4th April 2024 Dividend yield will be 6.8%, which is higher than the industry average of 3.6%. Sustainability & Growth Dividend is covered by earnings (57% earnings payout ratio) but not covered by cash flows (269% cash payout ratio). The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 24% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Feb 22
First half 2024 earnings released: EPS: AU$0.75 (vs AU$0.50 in 1H 2023) First half 2024 results: EPS: AU$0.75 (up from AU$0.50 in 1H 2023). Revenue: AU$176.1m (up 11% from 1H 2023). Net income: AU$30.0m (up 52% from 1H 2023). Profit margin: 17% (up from 12% in 1H 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Announcement • Feb 14
Lycopodium Limited to Report First Half, 2024 Results on Feb 21, 2024 Lycopodium Limited announced that they will report first half, 2024 results on Feb 21, 2024 Recent Insider Transactions • Dec 17
Executive Director recently sold AU$162k worth of stock On the 14th of December, Karl Cicanese sold around 15k shares on-market at roughly AU$10.73 per share. This transaction amounted to 7.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$1.2m more than they bought in the last 12 months. Upcoming Dividend • Sep 14
Upcoming dividend of AU$0.45 per share at 8.9% yield Eligible shareholders must have bought the stock before 21 September 2023. Payment date: 06 October 2023. Payout ratio is a comfortable 69% but the company is paying out more than the cash it is generating. Trailing yield: 8.9%. Within top quartile of Australian dividend payers (7.1%). Higher than average of industry peers (3.6%). Announcement • Aug 23
Lycopodium Limited Announces Franked Dividend for the Six Months Ended 30 June 2023, Payable on 6 October 2023 Lycopodium Limited announced Ordinary fully paid franked dividend of AUD 0.45000000 for the six months ended 30 June 2023. Record Date is 21 September 2023. Ex Date is 22 September 2023. Payment Date is 6 October 2023. Announcement • Aug 22
Lycopodium Limited, Annual General Meeting, Nov 14, 2023 Lycopodium Limited, Annual General Meeting, Nov 14, 2023, at 10:30 W. Australia Standard Time. Location: Fraser Suites Perth 10 Adelaide Terrace East Perth Western Australia Australia Reported Earnings • Aug 22
Full year 2023 earnings released: EPS: AU$1.18 (vs AU$0.68 in FY 2022) Full year 2023 results: EPS: AU$1.18 (up from AU$0.68 in FY 2022). Revenue: AU$327.6m (up 43% from FY 2022). Net income: AU$46.8m (up 72% from FY 2022). Profit margin: 14% (up from 12% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Announcement • Aug 15
Lycopodium Limited to Report Fiscal Year 2023 Results on Aug 22, 2023 Lycopodium Limited announced that they will report fiscal year 2023 results on Aug 22, 2023 Recent Insider Transactions • Apr 22
Non-Executive Director recently sold AU$1.0m worth of stock On the 20th of April, Rodney Leonard sold around 100k shares on-market at roughly AU$10.12 per share. This transaction amounted to 10.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$2.4m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to AU$10.02, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 14x in the Construction industry in Australia. Total returns to shareholders of 196% over the past three years. Upcoming Dividend • Mar 20
Upcoming dividend of AU$0.36 per share at 9.0% yield Eligible shareholders must have bought the stock before 27 March 2023. Payment date: 06 April 2023. Payout ratio is on the higher end at 90%, however this is supported by cash flows. Trailing yield: 9.0%. Within top quartile of Australian dividend payers (7.2%). Higher than average of industry peers (4.6%). Reported Earnings • Feb 23
First half 2023 earnings released: EPS: AU$0.50 (vs AU$0.38 in 1H 2022) First half 2023 results: EPS: AU$0.50 (up from AU$0.38 in 1H 2022). Revenue: AU$159.9m (up 57% from 1H 2022). Net income: AU$19.8m (up 29% from 1H 2022). Profit margin: 12% (down from 15% in 1H 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Announcement • Feb 15
Lycopodium Limited to Report First Half, 2023 Results on Feb 22, 2023 Lycopodium Limited announced that they will report first half, 2023 results on Feb 22, 2023 Board Change • Nov 17
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Non-Executive Director Louise Bower was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Sep 15
Upcoming dividend of AU$0.36 per share Eligible shareholders must have bought the stock before 22 September 2022. Payment date: 07 October 2022. Payout ratio is on the higher end at 79%, however this is supported by cash flows. Trailing yield: 11%. Within top quartile of Australian dividend payers (6.7%). Higher than average of industry peers (2.9%). Recent Insider Transactions • Aug 30
Executive Director recently sold AU$329k worth of stock On the 29th of August, Karl Cicanese sold around 50k shares on-market at roughly AU$6.57 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$1.2m more than they bought in the last 12 months. Reported Earnings • Aug 25
Full year 2022 earnings released: EPS: AU$0.68 (vs AU$0.36 in FY 2021) Full year 2022 results: EPS: AU$0.68 (up from AU$0.36 in FY 2021). Revenue: AU$228.7m (up 45% from FY 2021). Net income: AU$27.2m (up 91% from FY 2021). Profit margin: 12% (up from 9.0% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Jun 17
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 4.5%. The fair value is estimated to be AU$6.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 2.5%. Recent Insider Transactions • May 25
Non-Executive Director recently sold AU$450k worth of stock On the 20th of May, Rodney Leonard sold around 75k shares on-market at roughly AU$6.00 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$858k more than they bought in the last 12 months. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 1 independent director (6 non-independent directors). Independent Non-Executive Director Steve Chadwick was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Buying Opportunity • Apr 01
Now 21% undervalued Over the last 90 days, the stock is up 9.5%. The fair value is estimated to be AU$6.97, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 2.5%. Revenue is forecast to grow by 43% in 2 years. Earnings is forecast to decline by 7.8% in the next 2 years. Upcoming Dividend • Mar 21
Upcoming dividend of AU$0.18 per share Eligible shareholders must have bought the stock before 28 March 2022. Payment date: 07 April 2022. Payout ratio is a comfortable 56% but the company is paying out more than the cash it is generating. Trailing yield: 6.5%. Within top quartile of Australian dividend payers (5.7%). Higher than average of industry peers (2.6%). Buying Opportunity • Mar 03
Now 22% undervalued Over the last 90 days, the stock is up 2.5%. The fair value is estimated to be AU$6.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 2.5% per annum over the last 3 years. Reported Earnings • Feb 25
First half 2022 earnings: EPS in line with analyst expectations despite revenue beat First half 2022 results: EPS: AU$0.38 (up from AU$0.15 in 1H 2021). Revenue: AU$102.1m (up 45% from 1H 2021). Net income: AU$15.3m (up 142% from 1H 2021). Profit margin: 15% (up from 8.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.3%. Over the next year, revenue is forecast to grow 38%, compared to a 37% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year. Valuation Update With 7 Day Price Move • Nov 20
Investor sentiment improved over the past week After last week's 16% share price gain to AU$5.22, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 18x in the Construction industry in Australia. Total returns to shareholders of 22% over the past three years. Upcoming Dividend • Sep 16
Upcoming dividend of AU$0.15 per share Eligible shareholders must have bought the stock before 23 September 2021. Payment date: 08 October 2021. Trailing yield: 5.3%. Within top quartile of Australian dividend payers (5.1%). Higher than average of industry peers (4.0%). Reported Earnings • Aug 27
Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.30 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: AU$162.2m (down 23% from FY 2020). Net income: AU$14.2m (up 20% from FY 2020). Profit margin: 8.8% (up from 5.6% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Board Change • Aug 06
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. 2 independent directors (6 non-independent directors). Independent Non-Executive Director Steve Chadwick was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Feb 25
First half 2021 earnings released: EPS AU$0.15 (vs AU$0.23 in 1H 2020) The company reported a soft first half result with weaker earnings and revenues, although profit margins were improved. First half 2021 results: Revenue: AU$70.7m (down 36% from 1H 2020). Net income: AU$6.32m (down 30% from 1H 2020). Profit margin: 8.9% (up from 8.2% in 1H 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Jan 22
New 90-day high: AU$5.89 The company is up 48% from its price of AU$3.98 on 23 October 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Construction industry, which is up 18% over the same period. Is New 90 Day High Low • Jan 08
New 90-day high: AU$5.05 The company is up 26% from its price of AU$4.00 on 09 October 2020. The Australian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Construction industry, which is up 14% over the same period. Is New 90 Day High Low • Dec 08
New 90-day high: AU$4.87 The company is up 14% from its price of AU$4.28 on 08 September 2020. The Australian market is up 11% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Construction industry, which is up 28% over the same period. Valuation Update With 7 Day Price Move • Nov 27
Market bids up stock over the past week After last week's 19% share price gain to AU$4.86, the stock is trading at a trailing P/E ratio of 16.4x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 19x in the Construction industry in Australia. Total returns to shareholders over the past three years are 37%. Recent Insider Transactions • Oct 22
Non-Executive Director recently sold AU$390k worth of stock On the 20th of October, Rodney Leonard sold around 100k shares on-market at roughly AU$3.90 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$352k more than they bought in the last 12 months.